Long-Term Prognosis for 1-Year Relapse-Free Survivors of CD34+ Cell-Selected Allogeneic Hematopoietic Stem Cell Transplantation: A Landmark Analysis
Bone Marrow Transplantation - United Kingdom
doi 10.1038/bmt.2017.197
Full Text
Open PDFAbstract
Available in full text
Date
October 9, 2017
Authors
Publisher
Springer Science and Business Media LLC